Matthew Daley to Alendronate
This is a "connection" page, showing publications Matthew Daley has written about Alendronate.
Connection Strength
0.093
-
Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial. Ann Intern Med. 1999 Dec 21; 131(12):935-42.
Score: 0.044
-
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med. 1998 Feb 19; 338(8):485-92.
Score: 0.039
-
Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res. 1999 Sep; 14(9):1622-7.
Score: 0.011